Results 111 to 120 of about 15,338 (177)

A retrospective analysis of the prevalence of hypophosphatemia and hypocalcemia after intravenous iron polymaltose in the inpatient setting. [PDF]

JBMR Plus
Burrage LC, Llewellyn S, Foyn L, Pretorius C, Lazarus S.   +4 more
europepmc   +1 more source

Development of a severe rat refeeding syndrome model and mathematical modeling of the associated hypophosphatemia. [PDF]

NPJ Syst Biol Appl
Kato H, Yamaoka I, Kubota H.
europepmc   +1 more source

A case and review of fibroblast growth factor-23-mediated hypophosphatemic osteomalacia in the absence of pathogenic <i>PHEX</i> variants. [PDF]

JBMR Plus
Park YA, Gong JY, Chiang C, Trainer AH, Yates CJ.   +4 more
europepmc   +1 more source

Mineral disorders after hematopoietic stem cell transplantation in patients receiving parenteral nutrition. [PDF]

Hematol Transfus Cell Ther
Hortencio TDR, Salamonde JDF, Springer AMM, Vigorito AC, Mendonça VA, Nogueira RJN.   +5 more
europepmc   +1 more source

Mesenchymal Tumor of the Hand Causing Tumor-Induced Osteomalacia. [PDF]

Cureus
Cecil A, Shagi M, Haider SB, Gardezi SAA.   +3 more
europepmc   +1 more source

Autoimmune osteomalacia: a novel FGF23-related hypophosphatemic osteomalacia. [PDF]

J Bone Miner Metab
Hoshino Y, Ito N.
europepmc   +1 more source

"Double trouble": the impact of iron infusion and antiresorptive therapy on calcium-phosphate homeostasis. [PDF]

JBMR Plus
Stokes G, Sheu A, Girgis CM, White CP.
europepmc   +1 more source

Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate. [PDF]

J Clin Med
Tavčar LB, Lučovnik M, Hrobat H, Gornik L, Preložnik Zupan I.   +4 more
europepmc   +1 more source

Pain medication use in patients with X-linked hypophosphatemia treated with burosumab: a retrospective real-world study. [PDF]

JBMR Plus
Macica CM, Li Z, Johnson B, Noman A, Park C, Woods GN.   +5 more
europepmc   +1 more source